Risk of Developing Cancer Up for Children With Congenital Heart Disease
By Elana Gotkine HealthDay Reporter
MONDAY, March 17, 2025 -- Children with congenital heart disease (CHD) have increased risk of developing cancer, according to a research letter published in the March 18 issue of Circulation.
Danbee Kang, Ph.D., from Sungkyunkwan University in Seoul, South Korea, and colleagues conducted a nationwide retrospective cohort study using the mother-child linked cohort from the Korean National Health Insurance Service database to examine the risk of developing cancer in newborns with CHD. Data were included for 3,550,113 first live births with singleton gestations from Jan. 1, 2005, to Dec. 31, 2019. Overall, 72,205 newborns had CHD.
The researchers found that the incidence of cancer was higher in newborns with versus without CHD during a median follow-up of 10.32 years (hazard ratio, 1.66). Compared to those without CHD, newborns with isolated valve or vessel lesions had a 2.29 times higher incidence of cancer, followed by those with complex CHD and isolated shunt lesions. Significant associations with CHD were seen for ovarian cancer, liver cancer, and non-Hodgkin lymphoma. In mothers who gave birth to newborns with CHD, the hazard ratio for cancer was 1.17. The hazard ratio was consistent after inverse probability treatment weighting.
"This nationwide study demonstrates a notable association between CHD in newborns and an elevated risk of cancer in both these newborns and their mothers," the authors write. "This insight into the multifaceted etiology of cancer in individuals with CHD calls for a multidisciplinary approach to care."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted March 2025
Read this next
Worse Mental Health Trajectories Seen for Survivors of Teen, Young Adult Cancer
WEDNESDAY, May 28, 2025 -- Survivors of adolescent and young adulthood (AYA) cancer have significantly worse mental health trajectories into middle or older adulthood, according...
ASCO: GLP-1 Receptor Agonists May Reduce Risk for Obesity-Related Cancer, All-Cause Death
WEDNESDAY, May 28, 2025 -- For adults with diabetes and obesity, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with a reduced risk for obesity-related...
ASCO: Alcohol-Associated Cancer Mortality Increased From 1990 to 2021
TUESDAY, May 27, 2025 -- Alcohol-associated cancer mortality increased from 1990 to 2021, according to a study presented at the annual meeting of the American Society of Clinical...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.